Invention Grant
- Patent Title: Mammalian somatic cell with modified RNA encoding reprogramming factors
-
Application No.: US17513253Application Date: 2021-10-28
-
Publication No.: US12054748B2Publication Date: 2024-08-06
- Inventor: Derrick James Rossi , Luigi Warren
- Applicant: Children's Medical Center Corporation
- Applicant Address: US MA Boston
- Assignee: Children's Medical Center Corporation
- Current Assignee: Children's Medical Center Corporation
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Nicole D. Kling
- The original application number of the division: US15692518 2017.08.31
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C07K14/435 ; C12N5/074 ; C12N15/11

Abstract:
Described herein are synthetic, modified RNAs for changing the phenotype of a cell, such as expressing a polypeptide or altering the developmental potential. Accordingly, provided herein are compositions, methods, and kits comprising synthetic, modified RNAs for changing the phenotype of a cell or cells. These methods, compositions, and kits comprising synthetic, modified RNAs can be used either to express a desired protein in a cell or tissue, or to change the differentiated phenotype of a cell to that of another, desired cell type.
Public/Granted literature
- US20220162565A1 SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF Public/Granted day:2022-05-26
Information query